RATIONALE: Despite overwhelming evidence of the importance of circadian rhythms in cardiovascular health and disease, little is known regarding the circadian regulation of intracellular signaling pathways controlling cardiac function and remodeling. OBJECTIVE: To assess circadian changes in processes dependent on the protein phosphatase calcineurin, relative to changes in phosphorylation of cardiac proteins, in normal, hypertrophic, and failing hearts. METHODS AND RESULTS: We found evidence of large circadian oscillations in calcineurin-dependent activities in the left ventricle of healthy C57BL/6 mice. Calcineurin-dependent transcript levels and nuclear occupancy of the NFAT (nuclear factor of activated T cells) regularly fluctuated as much as 20-fold over the course of a day, peaking in the morning when mice enter a period of rest. Phosphorylation of the protein phosphatase 1 inhibitor 1 (I-1), a direct calcineurin substrate, and phospholamban, an indirect target, oscillated directly out of phase with calcineurin-dependent signaling. Using a surgical model of cardiac pressure overload, we found that although calcineurin-dependent activities were markedly elevated, the circadian pattern of activation was maintained, whereas, oscillations in phospholamban and I-1 phosphorylation were lost. Changes in the expression of fetal gene markers of heart failure did not mirror the rhythm in calcineurin/NFAT activation, suggesting that these may not be direct transcriptional target genes. Cardiac function in mice subjected to pressure overload was significantly lower in the morning than in the evening when assessed by echocardiography. CONCLUSIONS: Normal, opposing circadian oscillations in calcineurin-dependent activities and phosphorylation of proteins that regulate contractility are disrupted in heart failure.
RATIONALE: Despite overwhelming evidence of the importance of circadian rhythms in cardiovascular health and disease, little is known regarding the circadian regulation of intracellular signaling pathways controlling cardiac function and remodeling. OBJECTIVE: To assess circadian changes in processes dependent on the protein phosphatase calcineurin, relative to changes in phosphorylation of cardiac proteins, in normal, hypertrophic, and failing hearts. METHODS AND RESULTS: We found evidence of large circadian oscillations in calcineurin-dependent activities in the left ventricle of healthy C57BL/6 mice. Calcineurin-dependent transcript levels and nuclear occupancy of the NFAT (nuclear factor of activated T cells) regularly fluctuated as much as 20-fold over the course of a day, peaking in the morning when mice enter a period of rest. Phosphorylation of the protein phosphatase 1inhibitor 1 (I-1), a direct calcineurin substrate, and phospholamban, an indirect target, oscillated directly out of phase with calcineurin-dependent signaling. Using a surgical model of cardiac pressure overload, we found that although calcineurin-dependent activities were markedly elevated, the circadian pattern of activation was maintained, whereas, oscillations in phospholamban and I-1 phosphorylation were lost. Changes in the expression of fetal gene markers of heart failure did not mirror the rhythm in calcineurin/NFAT activation, suggesting that these may not be direct transcriptional target genes. Cardiac function in mice subjected to pressure overload was significantly lower in the morning than in the evening when assessed by echocardiography. CONCLUSIONS: Normal, opposing circadian oscillations in calcineurin-dependent activities and phosphorylation of proteins that regulate contractility are disrupted in heart failure.
Authors: Jørn B Sande; Ivar Sjaastad; Ingvild B Hoen; Janny Bøkenes; Theis Tønnessen; Even Holt; Per K Lunde; Geir Christensen Journal: Cardiovasc Res Date: 2002-02-01 Impact factor: 10.787
Authors: Christopher L Antos; Timothy A McKinsey; Norbert Frey; William Kutschke; John McAnally; John M Shelton; James A Richardson; Joseph A Hill; Eric N Olson Journal: Proc Natl Acad Sci U S A Date: 2002-01-08 Impact factor: 11.205
Authors: Beverly A Rothermel; Kambeez Berenji; Paul Tannous; William Kutschke; Asim Dey; Bridgid Nolan; Ki-Dong Yoo; Elaine Demetroulis; Michael Gimbel; Barry Cabuay; Mohsen Karimi; Joseph A Hill Journal: Physiol Genomics Date: 2005-07-20 Impact factor: 3.107
Authors: Ali El-Armouche; Thomas Rau; Oliver Zolk; Diana Ditz; Torsten Pamminger; Wolfram-H Zimmermann; Elmar Jäckel; Sian E Harding; Peter Boknik; Joachim Neumann; Thomas Eschenhagen Journal: FASEB J Date: 2003-01-02 Impact factor: 5.191
Authors: Stela Florea; Ahmad Anjak; Wen-Feng Cai; Jiang Qian; Elizabeth Vafiadaki; Sarah Figueria; Kobra Haghighi; Jack Rubinstein; John Lorenz; Evangelia G Kranias Journal: Basic Res Cardiol Date: 2012-07-10 Impact factor: 17.165
Authors: Graham R McGinnis; Yawen Tang; Rachel A Brewer; Manoja K Brahma; Haley L Stanley; Gobinath Shanmugam; Namakkal Soorappan Rajasekaran; Glenn C Rowe; Stuart J Frank; Adam R Wende; E Dale Abel; Heinrich Taegtmeyer; Silvio Litovsky; Victor Darley-Usmar; Jianhua Zhang; John C Chatham; Martin E Young Journal: J Mol Cell Cardiol Date: 2017-07-20 Impact factor: 5.000
Authors: Maija Mutikainen; Tomi Tuomainen; Nikolay Naumenko; Jenni Huusko; Boris Smirin; Svetlana Laidinen; Krista Kokki; Heidi Hynynen; Seppo Ylä-Herttuala; Merja Heinäniemi; Jorge L Ruas; Pasi Tavi Journal: J Physiol Date: 2016-12-01 Impact factor: 5.182
Authors: Martin E Young; Rachel A Brewer; Rodrigo A Peliciari-Garcia; Helen E Collins; Lan He; Tana L Birky; Bradley W Peden; Emily G Thompson; Billy-Joe Ammons; Molly S Bray; John C Chatham; Adam R Wende; Qinglin Yang; Chi-Wing Chow; Tami A Martino; Karen L Gamble Journal: J Biol Rhythms Date: 2014-08 Impact factor: 3.182
Authors: J M Vicencio; M Estrada; D Galvis; R Bravo; A E Contreras; D Rotter; G Szabadkai; J A Hill; B A Rothermel; E Jaimovich; S Lavandero Journal: Mini Rev Med Chem Date: 2011-05 Impact factor: 3.862